AngioDynamics, Inc. (ANGO) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2020-05-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2020-05-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2020-05-31..
Borrowing debt
Overview →Financial period ending 2020-05-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2020-05-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2020-05-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2020-05-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | 0.00 USD | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | (m) | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value · Marketable Securities, Current · Debt Securities, Available-for-sale, Current |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 594.21M USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2020-05-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $594.21M | (m) |
| 2020-02-29 | (m) | (m) | $0.00 | (m) | (m) | (m) | $731.96M | (m) |
| 2019-11-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | $724.88M | (m) |
| 2019-08-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | $690.36M | (m) |
| 2019-05-31 | (m) | (m) | $7.50M | $124.41M | (m) | $227.64M | $836.44M | (m) |
| 2019-02-28 | (m) | (m) | $6.25M | $126.84M | (m) | $41.70M | $777.79M | (m) |
| 2018-11-30 | (m) | (m) | $5.00M | $139.27M | (m) | $44.17M | $783.96M | (m) |
| 2018-08-31 | (m) | (m) | $5.00M | $85.44M | (m) | $26.11M | $693.87M | (m) |
| 2018-05-31 | (m) | (m) | $5.00M | $86.62M | (m) | $75.41M | $705.47M | (m) |
| 2018-02-28 | (m) | (m) | $5.00M | $87.80M | (m) | $53.57M | $698.43M | (m) |
| 2017-11-30 | (m) | (m) | $5.00M | $88.97M | (m) | $51.12M | $697.81M | (m) |
| 2017-08-31 | (m) | (m) | $5.00M | $90.15M | (m) | $49.41M | $700.34M | (m) |
| 2017-05-31 | (m) | (m) | $5.00M | $91.32M | (m) | $48.76M | $707.96M | (m) |
| 2017-02-28 | (m) | (m) | $5.00M | $92.52M | (m) | $36.77M | $704.32M | (m) |
| 2016-11-30 | (m) | (m) | $5.00M | $110.16M | (m) | $36.87M | $712.17M | (m) |
| 2016-08-31 | (m) | (m) | $17.50M | (m) | (m) | $39.06M | $726.71M | (m) |
| 2016-05-31 | (m) | (m) | $16.25M | (m) | (m) | $33.99M | $727.06M | (m) |
| 2016-02-29 | (m) | (m) | $12.50M | (m) | (m) | $23.56M | $753.51M | (m) |
| 2015-11-30 | (m) | (m) | $11.25M | (m) | (m) | $20.64M | $760.37M | (m) |
| 2015-08-31 | (m) | (m) | $10.00M | (m) | (m) | $21.96M | $771.79M | (m) |
| 2015-05-31 | (m) | (m) | $8.75M | (m) | (m) | $20.08M | $773.62M | (m) |
| 2015-02-28 | (m) | (m) | $7.50M | (m) | (m) | $21.39M | $783.14M | (m) |
| 2014-11-30 | (m) | (m) | $6.25M | (m) | (m) | $16.57M | $799.33M | (m) |
| 2014-08-31 | (m) | (m) | $5.00M | (m) | (m) | $15.48M | $796.11M | (m) |
| 2014-05-31 | (m) | (m) | $5.00M | $137.66M | (m) | $17.91M | $800.15M | (m) |
| 2014-02-28 | (m) | (m) | $5.00M | (m) | (m) | $9.19M | $792.17M | (m) |
| 2013-11-30 | (m) | (m) | $5.00M | (m) | (m) | $17.02M | $795.49M | (m) |
| 2013-08-31 | (m) | (m) | $13.13M | $129.38M | (m) | $23.91M | $801.15M | (m) |
| 2013-05-31 | (m) | (m) | $7.50M | $135.00M | (m) | $23.95M | $791.58M | (m) |
| 2013-02-28 | (m) | (m) | $7.50M | $136.88M | (m) | $18.78M | $796.47M | (m) |
| 2012-11-30 | (m) | (m) | $7.50M | $138.75M | (m) | $21.48M | $778.95M | (m) |
| 2012-08-31 | (m) | (m) | $7.50M | $140.63M | (m) | $30.52M | $718.36M | (m) |
| 2012-05-31 | (m) | (m) | $7.50M | $142.50M | (m) | $37.58M | $721.77M | (m) |
| 2012-02-29 | (m) | (m) | $295.00K | $6.05M | (m) | $143.03M | $446.61M | (m) |
| 2011-11-30 | (m) | (m) | $290.00K | $6.13M | (m) | $136.32M | $443.59M | (m) |
| 2011-08-31 | (m) | (m) | $285.00K | $6.20M | (m) | $136.65M | $439.61M | (m) |
| 2011-05-31 | (m) | (m) | $275.00K | $6.28M | (m) | $131.54M | $437.42M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |